These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1019152)

  • 1. Structure/activity relationship of gemfibrozil (CI-719) and related compounds.
    Creger PL; Moersch GW; Neuklis WA
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):3-5. PubMed ID: 1019152
    [No Abstract]   [Full Text] [Related]  

  • 2. The hypolipidaemic effect of gemfibrozil (CI-719) in laboratory animals.
    Rodney G; Uhlendorf P; Maxwell RE
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):6-10. PubMed ID: 828263
    [No Abstract]   [Full Text] [Related]  

  • 3. Toleration and bioavailability of gemfibrozil in healthy men.
    Smith TC
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):24-7. PubMed ID: 798193
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of gemfibrozil upon platelet function and blood coagulation. Preliminary report.
    Rasi VP; Torstila I
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):109-11. PubMed ID: 1019149
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipokinetic studies with gemfibrozil (CI-719).
    Kissebah AH; Adams PA; Wynn V
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):94-7. PubMed ID: 190610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of gemfibrozil on lipolysis in dogs in vivo.
    Riemersma RA; Oliver MF
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):107-8. PubMed ID: 1019148
    [No Abstract]   [Full Text] [Related]  

  • 7. Gemfibrozil: a new lipid lowering agent. Open forum.
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):115-20. PubMed ID: 1019151
    [No Abstract]   [Full Text] [Related]  

  • 8. Preliminary observations on the effect of gemfibrozil on the excretion of faecal bile acids.
    Baird IM; Lewis B; Hill JM
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):112-4. PubMed ID: 1019150
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of CI-719 on lipolysis in rat adipose tissue.
    Elkeles RS; Ashwell M; Priest R; Durrant M
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):98-100. PubMed ID: 1019159
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypolipidaemic action of gemfibrozil in adult nephrotics.
    Eisalo A; Manninen V; Mälkönen M; Kuhlbäck B
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):47-8. PubMed ID: 798197
    [No Abstract]   [Full Text] [Related]  

  • 11. Properties of sterol biosynthesis in human leukocytes: effects of gemfibrozil.
    Betteridge DJ; Higgins MJ; Galton DJ
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):104-6. PubMed ID: 190606
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of Gemfibrozil on human serum apolipoproteins and on serum reserve cholesterol binding capacity (SRCBC).
    Børresen AL; Berg K; Dahlén G; Gillnäs T; Ericson C
    Artery; 1981; 9(1):77-86. PubMed ID: 7018466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential hypolipidemic agents. XIX. Synthesis and lipid-lowering properties of thiophene derivatives related to clofibrate.
    Gronowitz S; Svenson R; Bondesson G; Magnusson O; Stjernström NE
    Acta Pharm Suec; 1978; 15(5):361-7. PubMed ID: 747094
    [No Abstract]   [Full Text] [Related]  

  • 14. Potential hypolipidemic agents. XVII. Synthesis and plasma lipid-lowering properties of compounds related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate and ethyl 2-(4-chlorophenoxy)-2-methylpropionate.
    Högberg T; Bondesson G; Stjernström NE
    Acta Pharm Suec; 1977; 14(2):149-60. PubMed ID: 906832
    [No Abstract]   [Full Text] [Related]  

  • 15. Gemfibrozil--a new lipid lowering agent.
    Hodges RM
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):1-2. PubMed ID: 798192
    [No Abstract]   [Full Text] [Related]  

  • 16. Gemfibrozil--the effect of biliary cholesterol saturation of a new lipid-lowering agent and its comparison with clofibrate.
    Hall MJ; Nelson LM; Russell RI; Howard AN
    Atherosclerosis; 1981 Jul; 39(4):511-6. PubMed ID: 6942844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinogen bioassay and mutagenicity studies with the hypolipidemic agent gemfibrozil.
    Fitzgerald JE; Sanyer JL; Schardein JL; Lake RS; McGuire EJ; de la Iglesia FA
    J Natl Cancer Inst; 1981 Nov; 67(5):1105-16. PubMed ID: 7029098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New lipid-lowering drug now on the market.
    JAMA; 1982 Mar; 247(11):1540. PubMed ID: 6950126
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential hypolipidemic agents. XIV. Synthesis and plasma lipid-lowering properties of substituted biphenyls, diphenyl ethers and benzofurans related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate.
    Bondesson G; Högberg T; Misiorny A; Stjernström NE
    Acta Pharm Suec; 1976; 13(2):97-106. PubMed ID: 937013
    [No Abstract]   [Full Text] [Related]  

  • 20. Gemfibrozil--a new lipid lowering agent.
    Nash DT
    J Med; 1980; 11(2-3):107-16. PubMed ID: 6931871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.